Cargando…

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein

Alpha-synuclein (α-Syn) is a key protein involved in Parkinson's disease (PD) pathology. PD is characterized by the loss of dopaminergic neuronal cells in the substantia nigra pars compacta and the abnormal accumulation and aggregation of α-Syn in the form of Lewy bodies and Lewy neurites. More...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Benito, Mónica, Granado, Noelia, García-Sanz, Patricia, Michel, Anne, Dumoulin, Mireille, Moratalla, Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191035/
https://www.ncbi.nlm.nih.gov/pubmed/32390826
http://dx.doi.org/10.3389/fphar.2020.00356
_version_ 1783527795384647680
author Gómez-Benito, Mónica
Granado, Noelia
García-Sanz, Patricia
Michel, Anne
Dumoulin, Mireille
Moratalla, Rosario
author_facet Gómez-Benito, Mónica
Granado, Noelia
García-Sanz, Patricia
Michel, Anne
Dumoulin, Mireille
Moratalla, Rosario
author_sort Gómez-Benito, Mónica
collection PubMed
description Alpha-synuclein (α-Syn) is a key protein involved in Parkinson's disease (PD) pathology. PD is characterized by the loss of dopaminergic neuronal cells in the substantia nigra pars compacta and the abnormal accumulation and aggregation of α-Syn in the form of Lewy bodies and Lewy neurites. More precisely, the aggregation of α-Syn is associated with the dysfunctionality and degeneration of neurons in PD. Moreover, mutations in the SNCA gene, which encodes α-Syn, cause familial forms of PD and are the basis of sporadic PD risk. Given the role of the α-Syn protein in the pathology of PD, animal models that reflect the dopaminergic neuronal loss and the widespread and progressive formation of α-Syn aggregates in different areas of the brain constitute a valuable tool. Indeed, animal models of PD are important for understanding the molecular mechanisms of the disease and might contribute to the development and validation of new therapies. In the absence of animal models that faithfully reproduce human PD, in recent years, numerous animal models of PD based on α-Syn have been generated. In this review, we summarize the main features of the α-Syn pre-formed fibrils (PFFs) model and recombinant adeno-associated virus vector (rAAV) mediated α-Syn overexpression models, providing a detailed comparative analysis of both models. Here, we discuss how each model has contributed to our understanding of PD pathology and the advantages and weakness of each of them. SIGNIFICANCE: Here, we show that injection of α-Syn PFFs and overexpression of α-Syn mediated by rAAV lead to a different pattern of PD pathology in rodents. First, α-Syn PFFs models trigger the Lewy body-like inclusions formation in brain regions directly interconnected with the injection site, suggesting that there is an inter-neuronal transmission of the α-Syn pathology. In contrast, rAAV-mediated α-Syn overexpression in the brain limits the α-Syn aggregates within the transduced neurons. Second, phosphorylated α-Syn inclusions obtained with rAAV are predominantly nuclear with a punctate appearance that becomes diffuse along the neuronal fibers, whereas α-Syn PFFs models lead to the formation of cytoplasmic aggregates of phosphorylated α-Syn reminiscent of Lewy bodies and Lewy neurites.
format Online
Article
Text
id pubmed-7191035
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71910352020-05-08 Modeling Parkinson’s Disease With the Alpha-Synuclein Protein Gómez-Benito, Mónica Granado, Noelia García-Sanz, Patricia Michel, Anne Dumoulin, Mireille Moratalla, Rosario Front Pharmacol Pharmacology Alpha-synuclein (α-Syn) is a key protein involved in Parkinson's disease (PD) pathology. PD is characterized by the loss of dopaminergic neuronal cells in the substantia nigra pars compacta and the abnormal accumulation and aggregation of α-Syn in the form of Lewy bodies and Lewy neurites. More precisely, the aggregation of α-Syn is associated with the dysfunctionality and degeneration of neurons in PD. Moreover, mutations in the SNCA gene, which encodes α-Syn, cause familial forms of PD and are the basis of sporadic PD risk. Given the role of the α-Syn protein in the pathology of PD, animal models that reflect the dopaminergic neuronal loss and the widespread and progressive formation of α-Syn aggregates in different areas of the brain constitute a valuable tool. Indeed, animal models of PD are important for understanding the molecular mechanisms of the disease and might contribute to the development and validation of new therapies. In the absence of animal models that faithfully reproduce human PD, in recent years, numerous animal models of PD based on α-Syn have been generated. In this review, we summarize the main features of the α-Syn pre-formed fibrils (PFFs) model and recombinant adeno-associated virus vector (rAAV) mediated α-Syn overexpression models, providing a detailed comparative analysis of both models. Here, we discuss how each model has contributed to our understanding of PD pathology and the advantages and weakness of each of them. SIGNIFICANCE: Here, we show that injection of α-Syn PFFs and overexpression of α-Syn mediated by rAAV lead to a different pattern of PD pathology in rodents. First, α-Syn PFFs models trigger the Lewy body-like inclusions formation in brain regions directly interconnected with the injection site, suggesting that there is an inter-neuronal transmission of the α-Syn pathology. In contrast, rAAV-mediated α-Syn overexpression in the brain limits the α-Syn aggregates within the transduced neurons. Second, phosphorylated α-Syn inclusions obtained with rAAV are predominantly nuclear with a punctate appearance that becomes diffuse along the neuronal fibers, whereas α-Syn PFFs models lead to the formation of cytoplasmic aggregates of phosphorylated α-Syn reminiscent of Lewy bodies and Lewy neurites. Frontiers Media S.A. 2020-04-23 /pmc/articles/PMC7191035/ /pubmed/32390826 http://dx.doi.org/10.3389/fphar.2020.00356 Text en Copyright © 2020 Gómez-Benito, Granado, García-Sanz, Michel, Dumoulin and Moratalla http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gómez-Benito, Mónica
Granado, Noelia
García-Sanz, Patricia
Michel, Anne
Dumoulin, Mireille
Moratalla, Rosario
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
title Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
title_full Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
title_fullStr Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
title_full_unstemmed Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
title_short Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
title_sort modeling parkinson’s disease with the alpha-synuclein protein
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191035/
https://www.ncbi.nlm.nih.gov/pubmed/32390826
http://dx.doi.org/10.3389/fphar.2020.00356
work_keys_str_mv AT gomezbenitomonica modelingparkinsonsdiseasewiththealphasynucleinprotein
AT granadonoelia modelingparkinsonsdiseasewiththealphasynucleinprotein
AT garciasanzpatricia modelingparkinsonsdiseasewiththealphasynucleinprotein
AT michelanne modelingparkinsonsdiseasewiththealphasynucleinprotein
AT dumoulinmireille modelingparkinsonsdiseasewiththealphasynucleinprotein
AT moratallarosario modelingparkinsonsdiseasewiththealphasynucleinprotein